Literature DB >> 2143808

L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.

C G Goety, C M Tanner, J A Cohen, J A Thelen, V S Carroll, H L Klawans, R G Fariello.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143808     DOI: 10.1002/mds.870050317

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  13 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

2.  Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients.

Authors:  Miroslav Cuturic; Ruth K Abramson; Robert R Moran; James W Hardin; Elaine M Frank; Andrea A Sellers
Journal:  Neurol Sci       Date:  2013-01       Impact factor: 3.307

Review 3.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

4.  Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.

Authors:  Janett Eckmann; Laura E Clemens; Schamim H Eckert; Stephanie Hagl; Libo Yu-Taeger; Thierry Bordet; Rebecca M Pruss; Walter E Muller; Kristina Leuner; Huu P Nguyen; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-03-18       Impact factor: 5.590

Review 5.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

6.  Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Authors:  Tiago A Mestre; Maria João Forjaz; Philipp Mahlknecht; Francisco Cardoso; Joaquim J Ferreira; Ralf Reilmann; Cristina Sampaio; Christopher G Goetz; Esther Cubo; Pablo Martinez-Martin; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2018-01-03

Review 7.  Acetyl-L-carnitine for dementia.

Authors:  S Hudson; N Tabet
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 8.  Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.

Authors:  Dénes Zádori; Péter Klivényi; Imola Plangár; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

Review 9.  l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug.

Authors:  Santina Chiechio; Pier Luigi Canonico; Mariagrazia Grilli
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

10.  A Review of the Clinical Evidence for Complementary and Alternative Medicine in Huntington's Disease.

Authors:  Margaret Yu; Danny Bega
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.